Express Pharma
Home  »  Latest Updates  »  Multisorb Technologies to showcase optimal use of sorbent tech at Interphex

Multisorb Technologies to showcase optimal use of sorbent tech at Interphex

4

Multisorb’s Success Through Efficiency programme will offer a comprehensive approach to help companies quickly identify, select and dispense the optimal sorbent solution

Multisorb Technologies will highlight its ability to help pharmaceutical companies drive their success through the optimal use of sorbent technology at Interphex in New York City, April 26-28, 2016.

“By increasing efficiencies, pharmaceutical companies can reduce expenses without sacrificing quality,” said Chris Gilmor, Commercial Director, Multisorb’s Healthcare Packaging Group in the Americas. “Our Success through Efficiency programme is designed to help companies optimise their sorbent usage to increase operational efficiencies and reduce cost while improving quality.”

Multisorb’s Success Through Efficiency programme offers a comprehensive approach to help companies quickly identify, select and dispense the optimal sorbent solution. They are

• Simulations for product stability and faster market access: SimulSorb and SimulOx simulations use QbD-based modelling to quickly identify the optimal sorbent for desired shelf life. By eliminating costly sorbent ranging studies, our simulations can help get your product to market 6-12 months faster.

• Sorbent platforms for all requirements and complex issues: The technical team can help select the best platform for your packaging presentation to deliver the lowest possible net packaging cost. With standard and customisable drop-in, fit-in, and built-in platforms, the requirements for packaging applications can be met.

•Dispensing systems for cost effective and turnkey operations: By engineering sorbent platforms with their respective dispensers, MultiPacket system delivers maximum efficiency. The result is an industry leading dispenser output efficiency of >99.997 per cent and the lowest total cost of ownership.

Comments are closed.